M&A Review: United Technologies SELLS Rocketdyne, Dell BUYS Quest
Here are Monday’s top mergers and acquisitions:
United Technologies Corporation (NYSE:UTX) divests its Rocketdyne division to GenCorp, Inc. (NYSE:GY) for $550 million, as the former concentrates upon selling off its non-core units and focuses on closing its $16.5 billion Goodrich purchase. The firm will use the proceeds from the sale to repay a portion of the debt it took on to acquire Goodrich.
Don’t Miss: Apple’s Phantom iPhone Has a Ton of Buyers.
Synergy Pharmaceuticals, Inc. (SGYP) acquires Callisto Pharmaceuticals, which is a development stage bio-pharmaceutical firm that primarily concentrates upon the development of medications to treat gastrointestinal disorders and diseases.
The Federal Trade Commission okays Dell, Inc. (NASDAQ:DELL) to purchase the systems management software supplier Quest Software, Inc. (NASDAQ:QSFT). Observers are not surprised by the move, since Dell’s share of the systems management market is quite small compared to that of competitors IBM and Hewlett-Packard. The acquisition of Quest should aid Dell’s ambitions for turning its software operations into a $5 billion per year business, along with offering integrated hardware and software solutions for virtualization deployments.
Don’t Miss: Is Google Jazzing Up Its Email CROWN JEWEL?
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.